Pliant Therapeutics (PLRX) Revenue & Revenue Breakdown
Pliant Therapeutics Revenue Highlights
Latest Revenue (Y)
$1.58M
Pliant Therapeutics Revenue by Period
Pliant Therapeutics Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | $1.58M | -83.69% |
2022-12-31 | $9.69M | 27.91% |
2021-12-31 | $7.57M | -81.89% |
2020-12-31 | $41.82M | -26.70% |
2019-12-31 | $57.05M | 100.00% |
2018-12-31 | - | - |
Pliant Therapeutics Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-09-30 | - | 100.00% |
2024-06-30 | - | 100.00% |
2024-03-31 | - | -100.00% |
2023-12-31 | $4.84M | 100.00% |
2023-09-30 | - | -100.00% |
2023-06-30 | $248.00K | -81.38% |
2023-03-31 | $1.33M | -32.21% |
2022-12-31 | $1.97M | 32.59% |
2022-09-30 | $1.48M | -70.29% |
2022-06-30 | $4.99M | 299.44% |
2022-03-31 | $1.25M | -37.52% |
2021-12-31 | $2.00M | 24.16% |
2021-09-30 | $1.61M | -10.01% |
2021-06-30 | $1.79M | -17.71% |
2021-03-31 | $2.17M | -51.31% |
2020-12-31 | $4.46M | -7.25% |
2020-09-30 | $4.81M | 33.72% |
2020-06-30 | $3.60M | -87.56% |
2020-03-31 | $28.94M | -49.28% |
2019-12-31 | $57.05M | 100.00% |
2019-09-30 | - | 100.00% |
2019-06-30 | - | 100.00% |
2019-03-31 | - | 100.00% |
2018-03-31 | - | - |
Pliant Therapeutics Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
ACLX | Arcellx | $110.32M | $26.03M |
ARVN | Arvinas | $78.50M | $102.40M |
RLAY | Relay Therapeutics | $25.55M | - |
RVMD | Revolution Medicines | $11.58M | - |
STOK | Stoke Therapeutics | $8.78M | $4.89M |
CYTK | Cytokinetics | $7.53M | $463.00K |
PLRX | Pliant Therapeutics | $1.58M | - |
VRDN | Viridian Therapeutics | $314.00K | $86.00K |
BDTX | Black Diamond Therapeutics | - | - |
INZY | Inozyme Pharma | - | - |
DYN | Dyne Therapeutics | - | - |
MDGL | Madrigal Pharmaceuticals | - | $62.17M |
PASG | Passage Bio | - | - |
SNDX | Syndax Pharmaceuticals | - | $12.50M |
ETNB | 89bio | - | - |